| Authors: |
Martorell A; Inflammatory Diseases Unit, Department of Dermatology, Venereology and Surgery, Hospital de Manises, Avenida Generalitat 50, 46940, Valencia, Spain. antmarto@hotmail.com., Ingram JR; Division of Infection and Immunity, Department of Dermatology and Academic Wound Healing, Cardiff University, Cardiff, UK., Sayed CJ; Department of Dermatology, University of North Carolina School of Medicine, Chapel Hill, NC, USA., Bechara FG; Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum, Bochum, Germany.; ICH-International Center for Hidradenitis Suppurativa/Acne Inversa, Ruhr-University Bochum, Bochum, Germany., Porter ML; Beth Israel Deaconess Medical Center, Department of Dermatology, Harvard Medical School, Boston, MA, USA., Tzellos T; Department of Dermatology, Nordland Hospital Trust, Bodø, Norway., Naik HB; Department of Dermatology, University of California, San Francisco, CA, USA., Kirby B; Department of Dermatology, St Vincent's University Hospital, Dublin, Ireland., van Straalen KR; Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands., Frew JW; University of New South Wales Sydney, Sydney, Kensington, Australia., Alarcon I; Novartis Pharma AG, Basel, Switzerland., Jordan M V; Novartis Pharma AG, Basel, Switzerland., Garg A; Northwell, New Hyde Park, NY, USA. |
